BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 15738393)

  • 1. MET and MYC cooperate in mammary tumorigenesis.
    Welm AL; Kim S; Welm BE; Bishop JM
    Proc Natl Acad Sci U S A; 2005 Mar; 102(12):4324-9. PubMed ID: 15738393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Signal transduction pathways activated and required for mammary carcinogenesis in response to specific oncogenes.
    Amundadottir LT; Leder P
    Oncogene; 1998 Feb; 16(6):737-46. PubMed ID: 9488037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic interaction of transforming growth factor alpha and c-myc in mouse mammary and salivary gland tumorigenesis.
    Amundadottir LT; Johnson MD; Merlino G; Smith GH; Dickson RB
    Cell Growth Differ; 1995 Jun; 6(6):737-48. PubMed ID: 7669729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Met signaling regulates growth, repopulating potential and basal cell-fate commitment of mammary luminal progenitors: implications for basal-like breast cancer.
    Gastaldi S; Sassi F; Accornero P; Torti D; Galimi F; Migliardi G; Molyneux G; Perera T; Comoglio PM; Boccaccio C; Smalley MJ; Bertotti A; Trusolino L
    Oncogene; 2013 Mar; 32(11):1428-40. PubMed ID: 22562252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Humanization of the mouse mammary gland by replacement of the luminal layer with genetically engineered preneoplastic human cells.
    Verbeke S; Richard E; Monceau E; Schmidt X; Rousseau B; Velasco V; Bernard D; Bonnefoi H; MacGrogan G; Iggo RD
    Breast Cancer Res; 2014 Dec; 16(6):504. PubMed ID: 25527189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. c-Kit is required for growth and survival of the cells of origin of Brca1-mutation-associated breast cancer.
    Regan JL; Kendrick H; Magnay FA; Vafaizadeh V; Groner B; Smalley MJ
    Oncogene; 2012 Feb; 31(7):869-83. PubMed ID: 21765473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of miR-489 derails mammary hierarchy structure and inhibits HER2/neu-induced tumorigenesis.
    Patel Y; Soni M; Awgulewitsch A; Kern MJ; Liu S; Shah N; Singh UP; Chen H
    Oncogene; 2019 Jan; 38(3):445-453. PubMed ID: 30104710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myc/p53 interactions in transgenic mouse mammary development, tumorigenesis and chromosomal instability.
    McCormack SJ; Weaver Z; Deming S; Natarajan G; Torri J; Johnson MD; Liyanage M; Ried T; Dickson RB
    Oncogene; 1998 May; 16(21):2755-66. PubMed ID: 9652742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wnt-1 and int-2 mammary oncogene effects on the beta-catenin pathway in immortalized mouse mammary epithelial cells are not sufficient for tumorigenesis.
    Hollmann CA; Kittrell FS; Medina D; Butel JS
    Oncogene; 2001 Nov; 20(52):7645-57. PubMed ID: 11753642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis.
    Cabodi S; Tinnirello A; Di Stefano P; Bisarò B; Ambrosino E; Castellano I; Sapino A; Arisio R; Cavallo F; Forni G; Glukhova M; Silengo L; Altruda F; Turco E; Tarone G; Defilippi P
    Cancer Res; 2006 May; 66(9):4672-80. PubMed ID: 16651418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mnt-deficient mammary glands exhibit impaired involution and tumors with characteristics of myc overexpression.
    Toyo-oka K; Bowen TJ; Hirotsune S; Li Z; Jain S; Ota S; Escoubet-Lozach L; Garcia-Bassets I; Lozach J; Rosenfeld MG; Glass CK; Eisenman R; Ren B; Hurlin P; Wynshaw-Boris A
    Cancer Res; 2006 Jun; 66(11):5565-73. PubMed ID: 16740691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of mouse mammary tumours in a transplantation system by the sequential introduction of the myc and ras oncogenes.
    Bradbury JM; Sykes H; Edwards PA
    Int J Cancer; 1991 Jul; 48(6):908-15. PubMed ID: 1860737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. c-MYC induces mammary tumorigenesis by means of a preferred pathway involving spontaneous Kras2 mutations.
    D'Cruz CM; Gunther EJ; Boxer RB; Hartman JL; Sintasath L; Moody SE; Cox JD; Ha SI; Belka GK; Golant A; Cardiff RD; Chodosh LA
    Nat Med; 2001 Feb; 7(2):235-9. PubMed ID: 11175856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The epigenetic modifier JMJD6 is amplified in mammary tumors and cooperates with c-Myc to enhance cellular transformation, tumor progression, and metastasis.
    Aprelikova O; Chen K; El Touny LH; Brignatz-Guittard C; Han J; Qiu T; Yang HH; Lee MP; Zhu M; Green JE
    Clin Epigenetics; 2016; 8():38. PubMed ID: 27081402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mammary epithelial reconstitution with gene-modified stem cells assigns roles to Stat5 in luminal alveolar cell fate decisions, differentiation, involution, and mammary tumor formation.
    Vafaizadeh V; Klemmt P; Brendel C; Weber K; Doebele C; Britt K; Grez M; Fehse B; Desriviéres S; Groner B
    Stem Cells; 2010 May; 28(5):928-38. PubMed ID: 20235097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transgenic expression of tpr-met oncogene leads to development of mammary hyperplasia and tumors.
    Liang TJ; Reid AE; Xavier R; Cardiff RD; Wang TC
    J Clin Invest; 1996 Jun; 97(12):2872-7. PubMed ID: 8675700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted c-myc gene expression in mammary glands of transgenic mice induces mammary tumours with constitutive milk protein gene transcription.
    Schoenenberger CA; Andres AC; Groner B; van der Valk M; LeMeur M; Gerlinger P
    EMBO J; 1988 Jan; 7(1):169-75. PubMed ID: 2834201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myc is required for β-catenin-mediated mammary stem cell amplification and tumorigenesis.
    Moumen M; Chiche A; Decraene C; Petit V; Gandarillas A; Deugnier MA; Glukhova MA; Faraldo MM
    Mol Cancer; 2013 Oct; 12(1):132. PubMed ID: 24171719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of Bcl-2 inhibits alveolar cell apoptosis during involution and accelerates c-myc-induced tumorigenesis of the mammary gland in transgenic mice.
    Jäger R; Herzer U; Schenkel J; Weiher H
    Oncogene; 1997 Oct; 15(15):1787-95. PubMed ID: 9362445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence that transgenes encoding components of the Wnt signaling pathway preferentially induce mammary cancers from progenitor cells.
    Li Y; Welm B; Podsypanina K; Huang S; Chamorro M; Zhang X; Rowlands T; Egeblad M; Cowin P; Werb Z; Tan LK; Rosen JM; Varmus HE
    Proc Natl Acad Sci U S A; 2003 Dec; 100(26):15853-8. PubMed ID: 14668450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.